Disclaimer

The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • 7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • +886-2-77201070
  • info@gravitycapital.com
  • Disclaimer

    The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

    In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • address:
    7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • tel:
    +886-2-77201070
  • email:
    info@gravitycapital.com
  • Shanghai Lionrun COVID-19 Antigen Test Kit, Nucleic Acid Test Kit Passes European Union CE Certification, Officially Entering International Market

    Release time: 2020-08-06Number of visits:800author:admin

    August 3rd,2020, Shanghai Lionrun SARS-CoV-2 diagnostics pipelines welcome 2 new members: SARS-CoV-2 Rapid Antigen test kit, and SARS-CoV-2 Rapid Nucleic Acid test kit. Both products have gained European Union CE certification, as we continue to provide the global fight against the COVID-19 accurate and efficient diagnostics tools. 

    SARS-CoV-2 Rapid Antigen test kit employs Immunochromatography (GICA) methods, applicable for detecting SARS-CoV-2 virus Antigen N protein from human nose swabs, throat swabs, and sinus swabs. It overcomes the antigen testing kits main weaknesses, that being unable to differentiate past or present infections; further aiding front-line healthcare workers to quickly make clinical decisions.

    SARS-CoV-2 Rapid Nucleic Acid test kit applies RT-RAA (Recombinase Aided Amplification) technology and LFD (Lateral Flow Dipstick) technology to achieve rapid and accurate detection of SARS-CoV-2. It uses only lateral flow dipstick to detect nucleic acids without using large PCR equipment, while giving us results easily identifiable by naked eye, faster, and just as sensitive as PCR tests. Currently this product is undergoing clinical trial in Chongqing public health centers, and in different clinical settings, different onset times, different disease stages yielded 100% positive results, while matching the results from RT-qPCR testing at 100%.

    Currently Shanghai Lionrun has a total of 3 different SARS-CoV-2 related test kits earing European Union green light to enter the EU market, becoming a world leader in SARS-CoV-2 test kits makers.

    We fight for the global battle against the pandemic!